Navigation Links
News tips from the Journal of Neuroscience
Date:8/14/2007

Spontaneous Astrocytic Ca2+ Oscillations and Neurite Growth
Kazunori Kanemaru, Yohei Okubo, Kenzo Hirose, and Masamitsu Iino

This week, Kanemaru et al. explore the signaling pathway between spontaneous Ca2+ oscillations in cultured astrocytes and the promotion of neurite growth. Their results reveal a role for the membrane-bound adhesion molecule N-cadherin. The authors blocked Ca2+ oscillations by preventing IP3 signaling with retroviral-mediated expression of IP3 5-phosphatase (5ppase). This molecule hydrolyzes IP3 and thus prevented spontaneous astrocytic Ca2+ oscillations. Growth cone motility was compromised in hippocampal neurons cultured with 5ppase-expressing astrocytes. Interference with neurotransmitter-evoked astrocytic Ca2+ transients did not affect neurite outgrowth. The messenger was not diffusible because direct contact with an astrocyte deficient in spontaneous Ca2+ signaling arrested growth cone advancement. Surface expression of the growth-promoting molecule N-cadherin was downregulated in 5ppase-expressing astrocytes, and neuronal growth cone advancement was rescued by extrinsic expression of N-cadherin on astrocytes.


Forming Filopodia
Yutaka Furutani, Hitomi Matsuno, Miwa Kawasaki, Takehiko Sasaki, Kensaku Mori, and Yoshihiro Yoshihara

Before synapses form between axons and dendrites, even before dendritic spines take shape, dendritic filopodia are out there, poking and prodding and exploring their surroundings. In this weeks Journal, Furutani et al. searched for intracellular binding partners for telencephalin (TLCN), atelencephalon- and dendrite-specific cell adhesion molecule that is expressed in filopodia. A yeast two-hybrid screen revealed interactions with ezrin, radixin, and moesin of the so-called ERM family; these adaptors link membrane proteins to the actin cytoskeleto
'/>"/>

Contact: Sara Harris
sharris@sfn.org
202-962-4000
Society for Neuroscience
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
3. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
4. Open Access journals get impressive impact factors
5. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
6. New journal article urges use of animal serum-free media for growing live cells
7. Impressive new Impact Factors for BioMed Centrals open-access journals
8. Public Library of Science to launch new, open access journal on neglected tropical diseases
9. Are journal rankings distorting science?
10. NIH neuroscience microarray consortium launches high-throughput genotyping services

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...y, November 20,2009 / b3c newswire / - KINAXO Bi...financing round, gaining two new investors in the ...me KINAXO reports that Jrgen Schumacher has been e...ard. , KINAXO shareholders Axel Ullrich, Hellmut...institutional investors Mountain Partners, BioM, H...
(Date:11/20/2009)...ort published in the November 2009 issue of the jo...ntists show how a family of genes (1-aminocyclopro...ponsible for production of ethylene. This gas affe...formation lays the foundation for future genetic m...nt, able to survive and thrive in difficult terrai...
(Date:11/20/2009)...ise measurements of plasma lipoprotein concentrati...roscopy (NMR), researchers led by Daniel Chasman a... School in Boston, MA, the Framingham Heart Study ...ckholm, Sweden and Oxford, England performed genet...ong 17,296 women of European ancestry from the Wom...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3It's a gas: New discovery may lead to heartier, high-yielding plants 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 1Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 2Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility 14603 3NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 1NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 2NxStage 28R 29 Reports Significant Interim FREEDOM Study Results 5732 3Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 1Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 2Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 3Logical Therapeutics Announces Positive Results of LT NS001 vs Naproxen Clinical Study 5727 4
...ken a "snapshot" of a Velcro-like protein on a cel...irus, a linkup thought to initiate the early stage...squitoes, infects more than 50 million people annu... tropical regions. , During the earliest stages o...bohydrate recognition domain," or CRD, of a key bi...
... molecule which they believe could ultimately lead... genetically modified tobacco. Writing in Plant Bi...agues from St George,s, University of London along... they have overcome a major barrier that has so fa...ally viable "bioreactors" for vaccines. , By creat...
...ls and immune cells called macrophages may be a so...the effectiveness of androgen antagonists, the mos...er, according to a new study by researchers at the... of Medicine. , Male hormones called androgens a...owth of the prostate gland, and anti-androgen trea...
Other Biology News:Biologists visualize protein interaction that may initiate viral infection 2Biologists visualize protein interaction that may initiate viral infection 3Do plants have the potential to vaccinate against HIV? 2Macrophage signaling may affect hormone resistance in prostate tumors 2
(Date:11/20/2009)...cently announced that Dr. Dominique Hebrault will ... Analytical Technology (PAT) in Green Chemistry an... (PRWEB) November 20, 2009...hnology (PAT) in Green Chemistry and Green Enginee...chnology (PAT) case studies will be presented on h...
(Date:11/19/2009)...ire/ -- Dr. Mate Hidvegi, inventor of Avemar ferme...se issued on November 17 by Biropharma Kft, discre...self-serving statements about its U.S. competitor ...om his office in Budapest, Hungary: ,, "The Bi...ply to AveULTRA, www.aveultra.com , is misleadi...
(Date:11/19/2009)...ss., Nov. 19 Arlington Medical Res...leading driver of antibiotic selection in nosocomi...against gram-positive and gram-negative pathogens....socomial pneumonia, surveyed European physicians r...vide appropriate coverage against common pathogens...
(Date:11/19/2009)...Synthesis Companies Form International Gene Synthe... in Risk Reduction ,Five Member Companies Repres...y , (PRWEB) November 19, ...thesis companies today announced agreement that th...te biosecurity in the gene synthesis industry. By...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...um to be held April 17, 2008, GRAND RAPIDS, Mich....Initiative (WMSTI) is accepting exhibitor applicat...nual Life Science Business,Showcase, Night at the ..., Night at the Museum is seeking regional exhibit... from up-and-coming startups in pharma research to...
... Feb. 19 National Stem,Cell Holding, Inc. (OTC: N... Arnold Securities, Inc. ("BMA Securities") to pro... respect to assisting and advising the,company wit...urities is a FINRA member full service brokerage f...al services, which include: market,making, institu...
...February 19 ChemAxon, a software,solutions provid...of,version 5 of their cheminformatics toolkits, Ma...n Marvin user friendliness, Markush enumeration an... Oracle Cartridge,performance., Marvin & JChem is...I,s),and graphic user interfaces (GUI,s) used by l...
Other Biology Technology:West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase 2National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000 2ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance 2
...an B4i ventilated and BR4i refrigerated multifunct...and low speed operation at a low sound level with ...for biocontainment. Their AUTO-LOCK rotor exchange...tor is ready for use within seconds. Instant rot...
...bank refrigerators: ,Each upright model provides ...erior 4C temperature uniformity for refrigerated b... Surveillance Module for complete blood storage mo... equipped with the HemaPro 101 alarm/monitor. All ...
Electroporation Cuvettes, 4 mm gap. 50 from Thermo Scientific
...rotease is an enhanced form of Tobacco Etch Virus ...y active, and significantly more stable than nativ...cTEV Protease specifically recognizes a seven amin...een Gln and Gly), making it useful for removing af...
Biology Products: